GNMSF vs VRTX: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Vertex Pharmaceuticals Inc in 2026
GNMSF
Genmab A/S
—
VRTX
Vertex Pharmaceuticals Inc
$480.50
Key Metrics Comparison
| Metric | GNMSF | VRTX | Winner |
|---|---|---|---|
| Market Cap | $14.85B | $106.87B | VRTX |
| P/E Ratio | 18.39 | 29.67 | GNMSF |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GNMSF
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or VRTX a better investment?
Comparing GNMSF and VRTX: Genmab A/S has a market cap of $14.85B while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and VRTX?
GNMSF (Genmab A/S) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or VRTX?
Based on P/E ratios, GNMSF trades at a lower multiple (18.4x vs 29.7x).
Which is growing faster: GNMSF or VRTX?
Both GNMSF and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GNMSF or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GNMSF or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $14.85B for GNMSF.
Should I buy GNMSF or VRTX in 2026?
Both GNMSF and VRTX have investment merit. GNMSF trades at $N/A while VRTX trades at $480.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and VRTX stock?
Key differences: Market Cap ($14.85B vs $106.87B), P/E Ratio (18.4x vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GNMSF or VRTX in 2026?
The choice between GNMSF and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GNMSF and VRTX?
GNMSF (Genmab A/S) has a market cap of $14.85B, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.